Bio-Works Technologies AB (publ) (NGM:BIOWKS)
Sweden · Delayed Price · Currency is SEK 2.490
-0.150 (-5.68%)
At close: Nov 5, 2025
Bio-Works Technologies AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 41.41 | 25.47 | 43.9 | 41.32 | 21.91 | 7.23 | Upgrade |
Other Revenue | -0.58 | 5.02 | - | - | 34.45 | - | Upgrade |
| 40.83 | 30.49 | 43.9 | 41.32 | 56.36 | 7.23 | Upgrade | |
Revenue Growth (YoY) | -6.78% | -30.55% | 6.23% | -26.68% | 679.09% | 29.83% | Upgrade |
Cost of Revenue | 11.31 | 5.45 | 17.08 | 12.47 | 3.35 | 3.02 | Upgrade |
Gross Profit | 29.52 | 25.04 | 26.82 | 28.85 | 53.01 | 4.22 | Upgrade |
Selling, General & Admin | 56.23 | 60.2 | 81.63 | 74.95 | 62.5 | 49.44 | Upgrade |
Other Operating Expenses | 0.41 | 0.12 | 2.09 | 0.57 | 0.76 | -0.27 | Upgrade |
Operating Expenses | 57.15 | 60.83 | 84.33 | 75.99 | 63.97 | 49.87 | Upgrade |
Operating Income | -27.64 | -35.8 | -57.5 | -47.14 | -10.96 | -45.65 | Upgrade |
Interest Expense | -0.07 | -0.01 | -0 | -0.02 | -0.02 | -0.01 | Upgrade |
Interest & Investment Income | 0.12 | 0.6 | 0.88 | 0.35 | 0.07 | 0.11 | Upgrade |
Currency Exchange Gain (Loss) | 0.93 | 0.93 | 1.89 | 2.12 | 1.53 | -0.21 | Upgrade |
Other Non Operating Income (Expenses) | -0.14 | -0 | - | 0 | - | -0 | Upgrade |
EBT Excluding Unusual Items | -26.81 | -34.28 | -54.73 | -44.7 | -9.37 | -45.76 | Upgrade |
Merger & Restructuring Charges | -3 | -3 | - | - | - | - | Upgrade |
Other Unusual Items | - | - | - | - | - | 0.74 | Upgrade |
Pretax Income | -29.81 | -37.28 | -54.73 | -44.7 | -9.37 | -45.02 | Upgrade |
Income Tax Expense | -0.03 | 0.08 | 2.09 | 0.26 | 3.57 | - | Upgrade |
Net Income | -29.78 | -37.36 | -56.82 | -44.95 | -12.94 | -45.02 | Upgrade |
Net Income to Common | -29.78 | -37.36 | -56.82 | -44.95 | -12.94 | -45.02 | Upgrade |
Shares Outstanding (Basic) | 79 | 50 | 36 | 35 | 31 | 30 | Upgrade |
Shares Outstanding (Diluted) | 79 | 50 | 36 | 35 | 31 | 30 | Upgrade |
Shares Change (YoY) | 97.09% | 38.31% | 3.16% | 12.17% | 2.60% | 0.50% | Upgrade |
EPS (Basic) | -0.38 | -0.75 | -1.57 | -1.28 | -0.41 | -1.48 | Upgrade |
EPS (Diluted) | -0.38 | -0.75 | -1.57 | -1.28 | -0.41 | -1.48 | Upgrade |
Free Cash Flow | -28.69 | -43.18 | -59.85 | -41 | -14.31 | -43.69 | Upgrade |
Free Cash Flow Per Share | -0.36 | -0.86 | -1.66 | -1.17 | -0.46 | -1.44 | Upgrade |
Gross Margin | 72.30% | 82.13% | 61.10% | 69.81% | 94.06% | 58.28% | Upgrade |
Operating Margin | -67.70% | -117.42% | -131.00% | -114.09% | -19.44% | -631.10% | Upgrade |
Profit Margin | -72.94% | -122.54% | -129.45% | -108.78% | -22.96% | -622.33% | Upgrade |
Free Cash Flow Margin | -70.27% | -141.63% | -136.34% | -99.23% | -25.39% | -603.88% | Upgrade |
EBITDA | -27.3 | -35.28 | -56.89 | -46.67 | -10.47 | -45.5 | Upgrade |
EBITDA Margin | -66.86% | -115.73% | -129.61% | -112.95% | -18.57% | - | Upgrade |
D&A For EBITDA | 0.34 | 0.51 | 0.61 | 0.47 | 0.49 | 0.15 | Upgrade |
EBIT | -27.64 | -35.8 | -57.5 | -47.14 | -10.96 | -45.65 | Upgrade |
EBIT Margin | -67.70% | -117.41% | -131.00% | -114.09% | -19.44% | - | Upgrade |
Revenue as Reported | 42.3 | 32.94 | 46.7 | 43.01 | 58.82 | 6.68 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.